Literature DB >> 9422258

Hyperthermic treatment of malignant diseases: current status and a view toward the future.

M W Dewhirst1, L Prosnitz, D Thrall, D Prescott, S Clegg, C Charles, J MacFall, G Rosner, T Samulski, E Gillette, S LaRue.   

Abstract

New studies in hyperthermia at the basic science, engineering, and clinical level have stimulated renewed enthusiasm for re-investigating its potential as an anticancer therapy. This article reviews the salient features of these recent results and points out areas for additional investigation. Highlighting these new results is the publication of several positive phase III trials for thermoradiotherapy compared to radiotherapy alone. Important highlights are the encouraging results using magnetic resonance imaging for noninvasive thermometry. If this technology is successfully implemented with real time power control it will revolutionize the clinical application of hyperthermia.

Entities:  

Mesh:

Year:  1997        PMID: 9422258

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  15 in total

1.  Thermal targeting of an acid-sensitive doxorubicin conjugate of elastin-like polypeptide enhances the therapeutic efficacy compared with the parent compound in vivo.

Authors:  Shama Moktan; Eddie Perkins; Felix Kratz; Drazen Raucher
Journal:  Mol Cancer Ther       Date:  2012-04-24       Impact factor: 6.261

Review 2.  Cell penetrating elastin-like polypeptides for therapeutic peptide delivery.

Authors:  Gene L Bidwell; Drazen Raucher
Journal:  Adv Drug Deliv Rev       Date:  2010-05-15       Impact factor: 15.470

3.  The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy.

Authors:  Andrew R Burke; Ravi N Singh; David L Carroll; James C S Wood; Ralph B D'Agostino; Pulickel M Ajayan; Frank M Torti; Suzy V Torti
Journal:  Biomaterials       Date:  2012-01-14       Impact factor: 12.479

Review 4.  Mild temperature hyperthermia and radiation therapy: role of tumour vascular thermotolerance and relevant physiological factors.

Authors:  Robert J Griffin; Ruud P M Dings; Azemat Jamshidi-Parsian; Chang W Song
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

Review 5.  Drug delivery to solid tumors by elastin-like polypeptides.

Authors:  Jonathan R McDaniel; Daniel J Callahan; Ashutosh Chilkoti
Journal:  Adv Drug Deliv Rev       Date:  2010-05-27       Impact factor: 15.470

Review 6.  Present and future technology for simultaneous superficial thermoradiotherapy of breast cancer.

Authors:  Eduardo G Moros; Jose Peñagaricano; Petr Novàk; William L Straube; Robert J Myerson
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

7.  Short-duration-focused ultrasound stimulation of Hsp70 expression in vivo.

Authors:  D E Kruse; M A Mackanos; C E O'Connell-Rodwell; C H Contag; K W Ferrara
Journal:  Phys Med Biol       Date:  2008-06-19       Impact factor: 3.609

8.  Anticancer activity of proapoptotic peptides is highly improved by thermal targeting using elastin-like polypeptides.

Authors:  Shama Moktan; Drazen Raucher
Journal:  Int J Pept Res Ther       Date:  2012-09       Impact factor: 1.931

9.  Feasibility of A-mode ultrasound attenuation as a monitoring method of local hyperthermia treatment.

Authors:  Noraida Abd Manaf; Maizatul Nadwa Che Aziz; Dzulfadhli Saffuan Ridzuan; Maheza Irna Mohamad Salim; Asnida Abd Wahab; Khin Wee Lai; Yan Chai Hum
Journal:  Med Biol Eng Comput       Date:  2016-04-02       Impact factor: 2.602

Review 10.  Carbon nanotubes in hyperthermia therapy.

Authors:  Ravi Singh; Suzy V Torti
Journal:  Adv Drug Deliv Rev       Date:  2013-08-08       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.